A clinical evaluation of clarithromycin in the treatment of pediatric infections
Furukawa, S.; Okada, T.
Japanese Journal of Antibiotics 42(2): 420-422
1989
ISSN/ISBN: 0368-2781 PMID: 2526255 Document Number: 342175
Clarithromycin (TE-031, A-56268) granules were used to treat various infections in the pediatric field and the results obtained are summarized as follows. 1. TE-031 was administered to a total of 10 patients (5 cases of enteritis, 4 cases of bronchitis and 1 case of tonsillitis). Clinical efficacies were excellent in 6 patients and good in 4 with an efficacy rate of 100%. 2. Neither side effects nor abnormal laboratory test values were observed. There was no rejection of drug disturbing the therapy.
Document emailed within 1 workday
Related Documents
Furukawa, S.; Okada, T. 1995: A clinical evaluation of SY5555 in the treatment of pediatric infections Japanese Journal of Antibiotics 48(2): 210-219Huang, L.M.; Lee, C.Y.; Lee, M.J.; Hsu, C.Y.; Liu, C.C.; Hong, J.Y.; Chen, J.M. 1989: A clinical evaluation of sulbactam/ampicillin in the treatment of pediatric infections Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi Zhonghua Minguo Xiao Er Ke Yi Xue Hui 30(2): 87-93
Solbiati, M.; Danzi, M.C.; D'Orazio, C.; Bassetti, D. 1988: Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections Chemioterapia: International Journal of the Mediterranean Society of ChemoTherapy 7(6): 393-395
Meguro, H.; Tajima, T.; Nonaka, C.; Mashiko, J.; Fujii, R.; Arimasu, O. 1984: Clinical evaluation of sulbactam/cefoperazone in the pediatric infections Japanese Journal of Antibiotics 37(10): 1821-1830
Ohnari, S.; Meguro, H.; Nonaka, C.; Tajima, T.; Takahashi, S.; Fujii, R. 1985: Clinical evaluation of cefminox, a new cephamycin antibiotic, in the pediatric infections Japanese Journal of Antibiotics 38(3): 671-678
Abad-Santos, F.; Gálvez-Múgica, M.A.; Espinosa de los Monteros, M.J.; Gallego-Sandín, S.; Novalbos, J. 2003: Meta-analysis of clarithromycin compared with other antimicrobial drugs in the treatment of upper respiratory tract infections Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 16(3): 313-324
Liou, J-Ming.; Chen, C-Yi.; Wu, M-Shiang.; Hsu, M-Tse.; Fang, C-Chung.; Lin, Y-Ling.; Chang, M-Chu.; Lin, J-Town.; Wang, H-Po. 2006: Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease Hepato-Gastroenterology 53(71): 792-796
Togami, K.; Chono, S.; Morimoto, K. 2012: Transport characteristics of clarithromycin, azithromycin and telithromycin, antibiotics applied for treatment of respiratory infections, in Calu-3 cell monolayers as model lung epithelial cells Die Pharmazie 67(5): 389-393
Szmytkowska, K. 2003: Clinical evaluation of hypospadias treatment outcome based on materials from the Pediatric Surgery ward Wiadomosci Lekarskie 56(5-6): 244-246
Okura, K.; Yamamoto, H.; Yamaoka, K.; Kubo, K.; Mitsuyoshi, I.; Haruta, T.; Kobayashi, Y. 1988: Clinical evaluation of ceftriaxone in the treatment of neonatal infections Japanese Journal of Antibiotics 41(2): 152-164
Sakamoto, M.; Mikasa, K.; Majima, T.; Konishi, M.; Maeda, K.; Yoshimoto, E.; Murakawa, K.; Takahashi, K.; Kita, E.; Narita, N. 2000: Usefulness of clarithromycin in paitents with unresectable non-small-cell lung cancer--clinical evaluation of those who survived for a long time and those succumbed in a short period Japanese Journal of Antibiotics 53 Suppl A: 56-59
Kubas, G.; Gospodarek, T. 1997: The use of clarithromycin and amoxycillin in pediatric acute otitis media Otolaryngologia Polska 51(Suppl 25): 165-167
Iutanova, N.S. 2004: Clinical efficacy of clarithromycin delayed release dosage form in the treatment of community-acquired pneumonia Antibiotiki i Khimioterapiia 49(3): 17-21
Gołabek, B.; Nowakowska, K.; Słowik, M.; Paruszkiewicz, G. 1995: Clinical evaluation of Uro-Vaxom in treatment of recurrent urinary tract infections in girls Pediatria Polska 70(12): 1053-1057
Kaseki, S.; Mano, T.; Tomoda, Y.; Kazato, S.; Asai, Y.; Sahara, K.; Manba, S.; Maruyama, T.; Kasugai, M.; Higashide, K.; Sekiya, H.; Mizutani, S.; Watanabe, K.; Ueno, K. 1983: Bacteriological and clinical evaluation of cefoxitin in the treatment of infections in 39 obstetric and gynecological patients Japanese Journal of Antibiotics 36(3): 509-521
Grechukhin, V.P.; Kostenko, V.B.; Suchkov, V.B.; Chirkin, I.D. 1972: Clinical-experimental evaluation of long-acting pencillin preparations in the treatment of anaerobic infections Voenno-Meditsinskii Zhurnal 4: 20-22
Beketov, A.S.; Sidorenko, S.V.; Pisarev, V.V.; Komarov, R.M. 2003: Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections Antibiotiki i Khimioterapiia 48(3): 34-41
Tsuda, S.; Nishigaki, H.; Okuda, T.; Horiike, S.; Yokota, S.; Yashige, H.; Taniwaki, M.; Misawa, S.; Takino, T.; Inazawa, J. 1988: Clinical evaluation of a combination treatment with cefmenoxime and cefsulodin of severe infections in leukemia and related disorders Japanese Journal of Antibiotics 41(5): 577-587
Zheng, X.-L.; Hu, F.-L.; Wang, W.-H.; Xu, L. 2009: Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains Zhonghua Yi Xue Za Zhi 89(22): 1558-1562
Benninger, P.; Cooper, A.; Moisan, R.; Patel, P.; Elvin, A.; Thiessen, J.J. 2004: A comparative clarithromycin bioavailability study: determination of clarithromycin and 14-(R)-hydroxyclarithromycin under fasting and fed conditions International Journal of Clinical Pharmacology and Therapeutics 42(6): 342-349